Survey reveals that current payment systems do not account for all of the time qualified healthcare professionals spend to interpret and integrate results with a patient’s diagnosis.
Read More
GenomOncology and UH Seidman Cancer Center enter into a partnership to increase clinical trial accrual rates.
Read More
Medical Diagnostic Laboratories’ approach blends DNA-based molecular testing with traditional pathology and cytology tests to aid in diagnosing or screening for urologic conditions.
Read More
Illumina’s NextSeq 550Dx platform and associated reagent kits received medical device registration in Russia, as have reagents for the MiSeqDx.
Read More
Strategic collaboration combines germline genetic testing, next-generation tumor sequencing, and testing capabilities to elevate precision oncology care.
Read More